Antoni Camins


Affiliation: Universitat de Barcelona
Country: Spain


  1. Camins A, Sureda F, Junyent F, Verdaguer E, Folch J, Pelegri C, et al. Sirtuin activators: designing molecules to extend life span. Biochim Biophys Acta. 2010;1799:740-9 pubmed publisher
    ..This review summarises current knowledge about the biological functions of SIRT1 in aging and aging-associated diseases and discusses its potential as a pharmacological target. ..
  2. request reprint
    Pallas M, Casadesus G, Smith M, Coto Montes A, Pelegri C, Vilaplana J, et al. Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection. Curr Neurovasc Res. 2009;6:70-81 pubmed
    ..In addition, we discuss the possibility of using resveratrol in the treatment of neurodegenerative diseases. ..
  3. Camins A, Verdaguer E, Junyent F, Yeste Velasco M, Pelegri C, Vilaplana J, et al. Potential mechanisms involved in the prevention of neurodegenerative diseases by lithium. CNS Neurosci Ther. 2009;15:333-44 pubmed publisher
  4. Pedrós I, Petrov D, Artiach G, Abad S, Ramon Duaso C, Sureda F, et al. Adipokine pathways are altered in hippocampus of an experimental mouse model of Alzheimer's disease. J Nutr Health Aging. 2015;19:403-12 pubmed publisher
    ..Taken together, these results demonstrate a significative impairment in adipokine receptors signalling and cholesterol regulation pathways in the hippocampus of APP/PS1 mice at an early age, prior to the Aβ plaque formation. ..
  5. Petrov D, Pedrós I, Artiach G, Sureda F, Barroso E, Pallas M, et al. High-fat diet-induced deregulation of hippocampal insulin signaling and mitochondrial homeostasis deficiences contribute to Alzheimer disease pathology in rodents. Biochim Biophys Acta. 2015;1852:1687-99 pubmed publisher
  6. Ettcheto M, Sánchez López E, Gómez Mínguez Y, Cabrera H, Busquets O, Beas Zarate C, et al. Peripheral and Central Effects of Memantine in a Mixed Preclinical Mice Model of Obesity and Familial Alzheimer's Disease. Mol Neurobiol. 2018;55:7327-7339 pubmed publisher
    ..These results provide new insight into the role of MEM not only in the occurrence of AD treatment, but also in its potential application on peripheral metabolic disorders where Aβ plays a key role, as is the case of T2DM. ..
  7. Peron R, Vatanabe I, Manzine P, Camins A, Cominetti M. Alpha-Secretase ADAM10 Regulation: Insights into Alzheimer's Disease Treatment. Pharmaceuticals (Basel). 2018;11: pubmed publisher
    ..Regulation of ADAM10 is achieved by multiple mechanisms that include transcriptional, translational and post-translational strategies, which we will summarize in this review. ..
  8. Folch J, Ettcheto M, Busquets O, Sánchez López E, Castro Torres R, Verdaguer E, et al. The Implication of the Brain Insulin Receptor in Late Onset Alzheimer's Disease Dementia. Pharmaceuticals (Basel). 2018;11: pubmed publisher
    ..Furthermore, we discuss AD treatment approaches targeting insulin signalling using anti-diabetic drugs and mTOR inhibitors. ..
  9. Busquets O, Ettcheto M, Pallàs M, Beas Zarate C, Verdaguer E, Auladell C, et al. Long-term exposition to a high fat diet favors the appearance of β-amyloid depositions in the brain of C57BL/6J mice. A potential model of sporadic Alzheimer's disease. Mech Ageing Dev. 2017;162:38-45 pubmed publisher
    ..The present findings confirm that HFD favors the formation of βA depositions in the brain, a key feature of AD, supporting the metabolic hypothesis of sporadic AD. ..

More Information


  1. Camins A, Junyent F, Verdaguer E, Beas Zarate C, Rojas Mayorquín A, Ortuño Sahagún D, et al. Resveratrol: An Antiaging Drug with Potential Therapeutic Applications in Treating Diseases. Pharmaceuticals (Basel). 2009;2:194-205 pubmed
    ..In the present review, we suggest that resveratrol may constitute a potential drug for prevention of ageing and for the treatment of several diseases due to its antioxidant properties and sirtuin activation. ..
  2. Folch J, Ettcheto M, Petrov D, Abad S, Pedrós I, Marin M, et al. Review of the advances in treatment for Alzheimer disease: Strategies for combating ?-amyloid protein. Neurologia. 2018;33:47-58 pubmed publisher
  3. Abad S, Ramon C, Pubill D, Camarasa J, Camins A, Escubedo E. Adolescent exposure to MDMA induces dopaminergic toxicity in substantia nigra and potentiates the amyloid plaque deposition in the striatum of APPswe/PS1dE9 mice. Biochim Biophys Acta. 2016;1862:1815-26 pubmed publisher
    ..Therefore, MDMA administration seems to anticipate the striatal dopaminergic dysfunction in this FAD model. The most important outcome lies in a potentiation, by MDMA, of the amyloid beta deposition in the striatum. ..
  4. Petrov D, Luque M, Pedrós I, Ettcheto M, Abad S, Pallas M, et al. Evaluation of the Role of JNK1 in the Hippocampus in an Experimental Model of Familial Alzheimer's Disease. Mol Neurobiol. 2016;53:6183-6193 pubmed publisher
    ..It may be necessary to inhibit both the JNK1 and JNK3 simultaneously, especially as previous studies suggest that JNK3 contributes to AD neuropathology. ..
  5. request reprint
    Auladell C, de Lemos L, Verdaguer E, Ettcheto M, Busquets O, Lazarowski A, et al. Role of JNK isoforms in the kainic acid experimental model of epilepsy and neurodegeneration. Front Biosci (Landmark Ed). 2017;22:795-814 pubmed
    ..In light of this, JNK3 could be a promising subcellular target for future therapeutic interventions in epilepsy. ..
  6. Folch J, Patraca I, Martínez N, Pedrós I, Petrov D, Ettcheto M, et al. The role of leptin in the sporadic form of Alzheimer's disease. Interactions with the adipokines amylin, ghrelin and the pituitary hormone prolactin. Life Sci. 2015;140:19-28 pubmed publisher
    ..In this review, we provide a general perspective on the functions of Lep in the brain, with a particular focus on the sporadic AD. ..
  7. Patraca I, Martínez N, Busquets O, Martí A, Pedrós I, Beas Zarate C, et al. Anti-inflammatory role of Leptin in glial cells through p38 MAPK pathway inhibition. Pharmacol Rep. 2017;69:409-418 pubmed publisher
    ..We suggest that Lep would act as an anti-inflammatory factor in glial cells exposed to pro-inflammatory cytokines, exerting its function on p38 MAPK pathway and reducing NO production. ..
  8. Ettcheto M, Sánchez López E, Pons L, Busquets O, Olloquequi J, Beas Zarate C, et al. Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways. Redox Biol. 2017;13:345-352 pubmed publisher
    ..Therefore, chronic DXI treatment could constitute a potential AD-modifying drug, both restoring cognitive functions and reversing multiple brain neuropathological hallmarks. ..
  9. Ettcheto M, Abad S, Petrov D, Pedrós I, Busquets O, Sánchez López E, et al. Early Preclinical Changes in Hippocampal CREB-Binding Protein Expression in a Mouse Model of Familial Alzheimer's Disease. Mol Neurobiol. 2018;55:4885-4895 pubmed publisher
  10. Busquets O, Ettcheto M, Verdaguer E, Castro Torres R, Auladell C, Beas Zarate C, et al. JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid. Neuropharmacology. 2018;131:440-452 pubmed publisher
    ..Thus, our results suggest that inhibition of the JNK1 by Lic-A has neuroprotective effects and that; it could be a new potential approach for the treatment of SE and neurodegeneration. ..
  11. Viveros Paredes J, Gonzalez Castañeda R, Gertsch J, Chaparro Huerta V, Lopez Roa R, Vázquez Valls E, et al. Neuroprotective Effects of ?-Caryophyllene against Dopaminergic Neuron Injury in a Murine Model of Parkinson's Disease Induced by MPTP. Pharmaceuticals (Basel). 2017;10: pubmed publisher
    ..These results indicate that BCP acts via multiple neuroprotective mechanisms in our murine model and suggest that BCP may be viewed as a potential treatment and/or preventative agent for PD. ..
  12. Ettcheto M, Petrov D, Pedrós I, de Lemos L, Pallàs M, Alegret M, et al. Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice. Exp Gerontol. 2015;65:69-78 pubmed publisher
    ..Further studies are necessary to understand the molecular pathways involved in memory loss in hypercholesterolemic LDLr -/- mice. ..
  13. request reprint
    Camins A, Verdaguer E, Folch J, Canudas A, Pallas M. The role of CDK5/P25 formation/inhibition in neurodegeneration. Drug News Perspect. 2006;19:453-60 pubmed
    ..Furthermore, the dual inhibitory effect of some of these drugs on cdk5 and GSK3beta could be beneficial. ..